Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. pharmacies to offer hearing aids by mid-October under new govt rule

Published 10/06/2022, 04:33 PM
Updated 10/06/2022, 04:46 PM
©  Reuters

By Bhanvi Satija

(Reuters) - Major U.S. pharmacy operators Walgreens Boots Alliance (NASDAQ:WBA) and Walmart (NYSE:WMT) Inc said on Thursday that in mid-October they would start selling hearing aids over-the-counter without the need for a medical exam, prescription, or audiologist fitting.

The companies are rolling out the products across the nation after the U.S. Food and Drug Administration in August issued a rule easing access to hearing aids for millions of Americans with mild to moderate hearing loss.

The rule, which goes into effect this month, should make it easier to buy lower-priced models.

Walgreens said it was planning to make Lexie Lumen hearing aids available at its stores across the country for adults starting Oct. 17 at a price of $799.

Walmart separately told Reuters it would begin offering hearing aids to adults with mild to moderate hearing loss without an assessment or medical exam by Oct. 17.

Products would start at $200 and will be available at Walmart.com and its vision centers.

Prior to allowing over-the-counter sale, these devices were only available at hearing centers and typically cost thousands of dollars. According to White House estimates, the change is expected to save consumers about $2,800 per pair.

In a statement to Reuters, CVS Health (NYSE:CVS) said it currently has a limited selection of hearing aids available on CVS.com, and it "plans to add to these offerings and expand to retail stores in the near future."

Hearing aids for severe hearing loss or for users below 18 years of age remain as prescription devices.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.